Virtus share price falls 5% as earnings plummet

The Virtus share price has fallen 2.8% this morning after the IVF provider released its full year results. We take a look at the details.

digitised image of IVF taking place representing Virtus share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Virtus Health Ltd (ASX: VRT) share price has fallen 4.7% this morning after the IVF provider released its full year results. At the time of writing, the Virtus share price is trading at $3.03 after closing yesterday's trade at $3.18. Virtus felt the impact of COVID-19 on demand for its services, seeing earnings per share fall 98.3%. Nonetheless it says trading activity has rebounded in July, providing confidence for FY21. 

What does Virtus Health do? 

Virtus Health is one of the largest reproductive services providers in the world. Operating in Australia, Ireland, and Denmark, with a growing presence in the United Kingdom and Singapore, Virtus Health provides a comprehensive range of fertility and IVF services. In Australia, the company operates seven day hospitals supporting its core IVF expertise and offers a range of general pathology services as well as specialist fertility and high-end genetic testing.

What did Virtus Health report? 

Virtus saw a 7.5% decline in revenue in FY20 which fell to $259 million. Lower IVF volumes resulted in a decrease in diagnostics revenue. Day hospitals were impacted by elective surgery restrictions and saw a decline in non-IVF procedure revenue. International revenues represented 19% of group revenues, with Danish and Irish revenue impacted by COVID-19 shutdowns. Nonetheless, the international business saw strong growth in fresh IVF cycles in June and July following the easing of restrictions in Europe. 

Reported group earnings before interest, taxes, depreciation and amortisation (EBITDA) fell 27.2% to $46.2 million, from $63.5 million in FY19. This decline was driven by an estimated gross profit loss of ~$14.6 million from lost revenue due to COVID-19 impacts on activity. Non cash impairment charges of $25 million were recognised which contributed to a 94.4% fall in NPAT attributable to shareholders. Having regard to the uncertainty in the current environment,  the board chose not to declare a final dividend. Nonetheless, the deferred interim dividend of 12 cents per share will be paid in November. 

What's next for the Virtus share price? 

Virtus Health has recently redefined its strategic direction, aiming to be the global leader in precision fertility. The company has been focused on optimising existing operations and developing virtual clinic technologies. This will enhance reach and reduce 'bricks and mortar' investment, driving significant efficiencies. Virtus says it is well positioned to manage any further disruption from COVID-19, with a continued focus on business development and margin improvement. Services have largely recommenced with COVID-19 highlighting the importance of family and IVF recognised as an essential service in the second wave in Victoria. The Virtus share price has risen 94% since its March low but is 35% lower in year-to-date trading. 

Motley Fool contributor Kate O'Brien has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Virtus Health Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

These were the best-performing ASX 200 shares in March

These shares made their shareholders smile in March thanks to some very big gains.

Read more »

Businessman using a digital tablet with a graphical chart, symbolising the stock market.
Opinions

2 ASX shares I have been buying in 2024!

I’m a believer in the long-term outlook of these stocks.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »